Panelists discuss how health care professionals have varying confidence in biosimilars, driven by concerns about efficacy, safety, and interchangeability. Increased education, real-world evidence, ...

Public investments in transportation yield a range of economic benefits, but those benefits have not accrued evenly in the U.S., due in part to policy and infrastructure investment decisions. As a ...

The promise of digital transformation, AI-driven efficiency, and hyper-resilient supply chains is colliding with a fundamental lack of confidence in its own data. The latest Dun & Bradstreet ...